Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emma E. Croushore"'
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 16, p 8595 (2024)
Ribonucleotide reductase (RNR) is the rate-limiting enzyme in the synthesis of deoxyribonucleotides and the target of multiple chemotherapy drugs, including gemcitabine. We previously identified that inhibition of RNR in Ewing sarcoma tumors upregula
Externí odkaz:
https://doaj.org/article/44f2127aeecf4e698c2b3617c6715ff1
Autor:
Darlene A. Mitrano, Sam E. Houle, Patrick Pearce, Ricardo M. Quintanilla, Blakely K. Lockhart, Benjamin C. Genovese, Rachel A. Schendzielos, Emma E. Croushore, Ethan M. Dymond, James W. Bogenpohl, Harold J. Grau, Lisa Smith Webb
Publikováno v:
IBRO Neuroscience Reports, Vol 10, Iss , Pp 51-61 (2021)
Alzheimer’s disease (AD) is an incurable neurodegenerative disease in which the risk of development increases with age. People with AD are plagued with deficits in their cognition, memory, and basic social skills. Many of these deficits are believe
Externí odkaz:
https://doaj.org/article/79bb64bd319c4de8be4b980ebf09e934
Autor:
Sam E. Houle, Rachel A. Schendzielos, Harold J. Grau, Darlene A. Mitrano, Emma E. Croushore, Patrick Pearce, Blakely K. Lockhart, James W. Bogenpohl, Lisa Smith Webb, Ethan M. Dymond, Benjamin C. Genovese, Ricardo M. Quintanilla
Publikováno v:
IBRO Neuroscience Reports
IBRO Neuroscience Reports, Vol 10, Iss, Pp 51-61 (2021)
IBRO Neuroscience Reports, Vol 10, Iss, Pp 51-61 (2021)
Alzheimer’s disease (AD) is an incurable neurodegenerative disease in which the risk of development increases with age. People with AD are plagued with deficits in their cognition, memory, and basic social skills. Many of these deficits are believe
Autor:
Emma E. Croushore, Patrick Pearce, Lisa Smith Webb, Benjamin C. Genovese, Ricardo M. Quintanilla, Harold J. Grau, Samuel Houle, Ethan M. Dymond, Rachel A. Schendzielos, Darlene A. Mitrano, Hanna Halleck‐Pinkleton
Publikováno v:
The FASEB Journal. 32
Autor:
Koppenhafer SL; Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Iowa, Iowa City, IA, 52242, USA., Goss KL; Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Iowa, Iowa City, IA, 52242, USA., Voigt E; Carver College of Medicine, University of Iowa, Iowa City, IA, 52242, USA., Croushore E; Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Iowa, Iowa City, IA, 52242, USA., Terry WW; Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Iowa, Iowa City, IA, 52242, USA., Ostergaard J; Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Minnesota, Minneapolis, MN, 55455, USA., Gordon PM; Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Minnesota, Minneapolis, MN, 55455, USA., Gordon DJ; Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Iowa, Iowa City, IA, 52242, USA. david-j-gordon@uiowa.edu.
Publikováno v:
Oncogene [Oncogene] 2022 May; Vol. 41 (20), pp. 2873-2884. Date of Electronic Publication: 2022 Apr 14.